Upcoming Exhibitions Meet BQ+ at Upcoming Medical Trade Shows BQ Plus Medical Co., Ltd will meet customers and partners at upcoming medical device exhibitions in
See how BQ+ improved its average on-time delivery rate from 62% in 2019 to 99% from 2023 to 2025, with 2026 year-to-date performance averaging 99.6%.
Are you looking for different kinds of medical products in the institution to fit different needs? The pump infusion set is referred to as the
In the current IV industry, many clinics, pharmacies, and home infusion firms are seeking more cost-effective ways to provide continuous infusions to their patients. One
Parenteral nutrition (PN) provides calories and necessary fatty acids to individuals who are unable to acquire enough nourishment orally or enterally. The Institute for Safe Drug Practices (ISMP) classifies parenteral nutrition (PN) as a medication requiring a high level of vigilance because to its significant potential for adverse effects.
We are proud to announce that in July 2022 we completed 185 customer orders with an On Time Delivery Rate of 100%!
If you’re running your health center or pharmacy then it becomes crucial to have the best collection of medical equipment. The intravenous filter are one
BQ+ Weekly #2 – Get an overview of the business in 1 min each week: BQ+ Weekly news
Infiltration infusion pump tubing is a nine-foot infiltration infusion pump tubing that features a Luer lock connection. Using a bag spike, peristaltic silicone tubing is pressure-locked to a six-foot stretch of tube. This segment of silicone tubing is intended for enhanced flow and simple insertion into the pump head.
BQ+ Weekly #1 – Get an overview of the business in 1 min each week: BQ+ Weekly news
BQ Plus Medical Co., Ltd., a professional medical device manufacturer focused on contract manufacturing of IV Administration and Extension Set, announced today that it has received 510(k) clearance for IV Administration Set and Extension Set from the U.S. Food and Drug Administration (FDA).
The market for medical devices in China is predicted to reach $130 billion in 2020, with an annual growth rate of 11 percent from 2020 to 2025. This expansion will continue to be driven by the growing incidence of chronic diseases, rising healthcare expenditures due to income growth
